4th Quarter - Report

ALSTON & BIRD LLP for CELGENE CORPORATION

Firm
Client
Income
$140,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

Discussion of ongoing trade issues.

LobbyistCovered position, as disclosed
ERIC SHIMP —

Contacted: U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; SENATE; Treasury, Dept of

Health Issues HCR

Issues relating to prescription drugs in health care bills; orphan drug and rare disease bills; Issues in S. 3187, the Food & Drug Administration Safety & Innovation Act.

Contacted: Treasury, Dept of; U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 3187 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.